BiotechTube
Home/Kailera Therapeutics/Ron Renaud
RR

Ron Renaud

President & Chief Executive Officer

Kailera Therapeutics

Roles

President & Chief Executive OfficeratKailera Therapeutics
Chair, Board of DirectorsatUpstream Bio

Therapeutic Areas

ObesityChronic Weight Management

Kailera Therapeutics Pipeline

DrugIndicationPhase
Ribupatide (KAI-9531) InjectableObesity / Chronic Weight ManagementPhase 3
Ribupatide OralObesity / Chronic Weight ManagementPhase 2
KAI-7535Obesity / Chronic Weight ManagementClinical
KAI-4729Obesity / Chronic Weight ManagementClinical

Leadership Team at Kailera Therapeutics

DP
Doug Pagán
Chief Financial Officer
View full Kailera Therapeutics profile